THE NUMBER OF AIDS-related deaths have been halved in the past 12 years, and more people than ever are receiving treatment for HIV, in a shift that’s seen as a victory against the stigmatised virus for which there’s no known cure.
AIDS claimed a million lives in 2016 – almost half the 2005 toll that marked the peak of the deadly epidemic.
The information was published in a United Nations report today, ahead of an AIDS science conference opening in Paris this Sunday.
“AIDS-related deaths have fallen from 1.9 million in 2005 to one million in 2016,” said the authors, adding that “for the first time the scales have tipped”.
“In 2016, 19.5 million of the 36.7 million people living with HIV had access to treatment,” said the UNAIDS global roundup. That data marks the first time that more than half of infected people were receiving anti-retroviral treatment, which subdues the AIDS virus but does not kill it.
Prince Harry meets Tlotlo Moilwa from Botswana, who is HIV positive, during a visit to the London School of Hygiene and Tropical Medicine.
Source: PA Images
The year 2016 saw 1.8 million new infections, almost half the record number of some 3.5 million in 1997, said the report.
In total, 76.1 million people have been infected with HIV – the virus that causes AIDS – since the epidemic started in the 1980s. Some 35 million have died.
“Communities and families are thriving as AIDS is being pushed back,” said UNAIDS executive director Michel Sidibe.
As we bring the epidemic under control, health outcomes are improving and nations are becoming stronger.
As yet, there is no HIV vaccine or cure, and infected people rely on lifelong anti-retroviral therapy to stop the virus replicating.
The HIV prevention drug Truvada – pictured in a doctor’s office in Berlin.
Source: Maurizio Gambarini via PA Images
Without treatment, HIV-infected people go on to develop AIDS, a syndrome that weakens the immune system and leaves the body exposed to opportunistic infections such as tuberculosis, and some types of cancer.
Treatment carries side effects and is costly, but allows infected people to be healthier for longer.
‘More work to do’
Most progress has been made in east and southern Africa, the region that was hardest hit by the epidemic and where many interventions were focused.
Since 2010, AIDS-related deaths in the region declined by 42%. The region accounts for half the world’s infected population, with women and girls disproportionately affected at 60%.
Sixty percent of all people who receive anti-retroviral therapy live in east and southern Africa which, along with west and central Europe and the Americas, is on target to meet the so-called 90-90-90 targets set by the UN, said the report.
By 2020, states the plan, 90% of infected people must know their status, of whom 90% must be on treatment. In 90% of those, the virus will be “suppressed” by medicine to the extent that it cannot function or replicate.
By 2016, 70% of infected people knew their status, said the new report. Of those, 77% were on treatment, and 82% had virus suppression.
UNAIDS expressed concern about two regions with worsening AIDS trends: the Middle East-North Africa, and eastern Europe-central Asia. Both are areas marred by conflict and political uncertainty.
New HIV infections rose by 60% in eastern Europe and central Asia, and deaths by almost a third from 2010 to 2016.
In the Middle East and North Africa, the number of AIDS deaths increased by a fifth in the last six years.
“Globally, progress has been significant, but there is still more work to do,” the authors said in a statement.
“Around 30% of people living with HIV still do not know their HIV status, 17.1 million people living with HIV do not have access to anti-retroviral therapy, and more than half of all people living with HIV are not virally suppressed.”
Of the total infected population, over two million were children younger than 15, said UNAIDS. Only 43% of them were on treatment.
New infections among children almost halved from 300,000 in 2010 to 160,000 last year, said the report.
This was partly due to more and more HIV-infected pregnant women – 76% in 2016 – having access to drugs blocking virus transmission to their offspring.